G-418 disulfate
CAS No. 108321-42-2
G-418 disulfate ( Geneticin sulfate )
Catalog No. M10328 CAS No. 108321-42-2
An aminoglycoside antibiotic similar in structure to gentamicin B1; blocks polypeptide synthesis by inhibiting the elongation step in both prokaryotic and eukaryotic cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
500MG | 38 | In Stock |
|
1G | 45 | In Stock |
|
Biological Information
-
Product NameG-418 disulfate
-
NoteResearch use only, not for human use.
-
Brief DescriptionAn aminoglycoside antibiotic similar in structure to gentamicin B1; blocks polypeptide synthesis by inhibiting the elongation step in both prokaryotic and eukaryotic cells.
-
DescriptionAn aminoglycoside antibiotic similar in structure to gentamicin B1; blocks polypeptide synthesis by inhibiting the elongation step in both prokaryotic and eukaryotic cells.
-
SynonymsGeneticin sulfate
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorOthers
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number108321-42-2
-
Formula Weight692.71
-
Molecular FormulaC20H44N4O18S2
-
Purity>98% (HPLC)
-
SolubilityH2O: ≥ 30 mg/mL
-
SMILESO[C@@H]1[C@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](C(O)C)[C@@H](O)[C@H](O)[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@](O)(C)[C@H]1NC.O=S(O)(O)=O
-
Chemical NameD-Streptamine, O-2-amino-2,7-dideoxy-D-glycero-α-D-gluco-heptopyranosyl-(1→4)-O-[3-deoxy-4-C-methyl-3-(methylamino)-β-L-arabinopyranosyl-(1→6)]-2-deoxy-, sulfate (1:2)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Rifabutin
A semisynthetic ansamycin antibiotic with potent antimycobacterial properties.
-
AAI-101
AAI-101 is a novel extended-spectrum β-lactamase inhibitor with activity against many β-lactamases, including some class A and class D carbapenemases.
-
PBP 10
Selective formyl peptide receptor 2 (FPR2) antagonist; cell permeable. Selectively inhibits FPR2-mediated NADPH oxidase activity but has no effect on FPR1 signaling in neutrophils. Displays PIP2 binding activity in vitro and blocks cell motility. Also exhibits antiviral activity against influenza viruses via inhibition of viral-induced ERK activation.